Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Verrelle

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2011
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trialJean Bourhis, Michel Lapeyre, Jacques Tortochaux, et al.
BMC Medicine|September 2, 2017
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypesJean-Philippe Foy, Louis Bazire, Sandra Ortiz-Cuaran, et al.
Journal of Neuro-Oncology|July 30, 2017
Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosisAnne Fogli, Marie-Véronique Demattei, Laetitia Corset, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2011
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intentJacques Tortochaux, Yungan Tao, Elodie Tournay, et al.
Biomedicines|September 23, 2022
Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain MetastasesJudith Porte, Caroline Saint-Martin, Thomas Frederic-Moreau, et al.
Genome Research|September 20, 2019
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanismsFranck Court, Elisa Le Boiteux, Anne Fogli, et al.
Human Molecular Genetics|March 17, 2022
L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locusMarie-Elisa Pinson, Franck Court, Aymeric Masson, et al.
Scientific Reports|November 7, 2015
Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compoundPatrick Merle, Marine Gueugneau, Marie-Paule Teulade-Fichou, et al.
International Journal of Cancer|January 19, 2007
Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective studyJacques-Olivier Bay, Bay Jacques-Olivier, Claude Linassier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trialJean Bourhis, Michel Lapeyre, Jacques Tortochaux, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 12, 2011
Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trialJean Bourhis, Michel Lapeyre, Jacques Tortochaux, et al.
BMC Medicine|September 2, 2017
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypesJean-Philippe Foy, Louis Bazire, Sandra Ortiz-Cuaran, et al.
Journal of Neuro-Oncology|July 30, 2017
Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosisAnne Fogli, Marie-Véronique Demattei, Laetitia Corset, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 12, 2011
Randomized phase III trial (GORTEC 98-03) comparing re-irradiation plus chemotherapy versus methotrexate in patients with recurrent or a second primary head and neck squamous cell carcinoma, treated with a palliative intentJacques Tortochaux, Yungan Tao, Elodie Tournay, et al.
Biomedicines|September 23, 2022
Efficacy and Safety of Combined Brain Stereotactic Radiotherapy and Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with Brain MetastasesJudith Porte, Caroline Saint-Martin, Thomas Frederic-Moreau, et al.
Genome Research|September 20, 2019
Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanismsFranck Court, Elisa Le Boiteux, Anne Fogli, et al.
Human Molecular Genetics|March 17, 2022
L1 chimeric transcripts are expressed in healthy brain and their deregulation in glioma follows that of their host locusMarie-Elisa Pinson, Franck Court, Aymeric Masson, et al.
Scientific Reports|November 7, 2015
Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compoundPatrick Merle, Marine Gueugneau, Marie-Paule Teulade-Fichou, et al.
International Journal of Cancer|January 19, 2007
Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective studyJacques-Olivier Bay, Bay Jacques-Olivier, Claude Linassier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trialJean Bourhis, Michel Lapeyre, Jacques Tortochaux, et al.
Pageof 9